These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26660168)

  • 1. Mass Spectrometry in Clinical Laboratory: Applications in Therapeutic Drug Monitoring and Toxicology.
    Garg U; Zhang YV
    Methods Mol Biol; 2016; 1383():1-10. PubMed ID: 26660168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass Spectrometry in Clinical Laboratory: Applications in Therapeutic Drug Monitoring and Toxicology.
    Victoria Zhang Y; Garg U
    Methods Mol Biol; 2024; 2737():1-13. PubMed ID: 38036805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
    Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid Chromatography-Tandem Mass Spectrometry: An Emerging Technology in the Toxicology Laboratory.
    Zhang YV; Wei B; Zhu Y; Zhang Y; Bluth MH
    Clin Lab Med; 2016 Dec; 36(4):635-661. PubMed ID: 27842783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Some thoughts on the links between LC-MS/MS and therapeutic drug monitoring].
    Saint-Marcoux F
    Ann Biol Clin (Paris); 2015; 73(1):49-53. PubMed ID: 25582722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and analytical toxicology of opiate, cocaine and amphetamine].
    Feliu C; Fouley A; Millart H; Gozalo C; Marty H; Djerada Z
    Ann Biol Clin (Paris); 2015; 73(1):54-69. PubMed ID: 25582723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring and LC-MS/MS.
    Adaway JE; Keevil BG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():33-49. PubMed ID: 21992751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC-MS (/MS) in clinical toxicology screening methods.
    Viette V; Hochstrasser D; Fathi M
    Chimia (Aarau); 2012; 66(5):339-42. PubMed ID: 22867548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations of point-of-care testing in the ED or ICU: a role for regional centralized toxicology laboratories.
    Wu AH
    Clin Pharmacol Ther; 2010 Sep; 88(3):295-8. PubMed ID: 20725077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of new exemestane metabolites by liquid chromatography interfaced to electrospray-tandem mass spectrometry.
    de Albuquerque Cavalcanti G; Carius Garrido B; Dias Leal F; Costa Padilha M; Mazzarino M; de la Torre X; Botre F; Radler de Aquino Neto F
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):248-54. PubMed ID: 21924357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain Management Testing by Liquid Chromatography Tandem Mass Spectrometry.
    Bodor GS
    Clin Lab Med; 2018 Sep; 38(3):455-470. PubMed ID: 30115391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid chromatography tandem-mass spectrometry (LC-MS/MS)--technique and applications in endocrinology.
    Vogeser M; Parhofer KG
    Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):559-70. PubMed ID: 17943689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress of liquid chromatography-mass spectrometry in clinical and forensic toxicology.
    Marquet P
    Ther Drug Monit; 2002 Apr; 24(2):255-76. PubMed ID: 11897972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of liquid chromatography-high resolution mass spectrometry in toxicological screening].
    Li XW; Shen BH; Zhuo XY
    Fa Yi Xue Za Zhi; 2011 Oct; 27(5):376-81. PubMed ID: 22259869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of multiple drugs of abuse and metabolites in urine using LC/MS/MS with polarity switching electrospray ionization.
    Shin M; Ji D; Kang S; Yang W; Choi H; Lee S
    Arch Pharm Res; 2014 Jun; 37(6):760-72. PubMed ID: 23918650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usage and limitations of liquid chromatography-tandem mass spectrometry (LC-MS/MS) in clinical routine laboratories.
    Seger C
    Wien Med Wochenschr; 2012 Nov; 162(21-22):499-504. PubMed ID: 23129542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen glucuronides analysis by liquid chromatography tandem-mass spectrometry: could it raise new perspectives in the diagnostic field of hormone-dependent malignancies?
    Kalogera E; Pistos C; Provatopoulou X; Athanaselis S; Spiliopoulou C; Gounaris A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 940():24-34. PubMed ID: 24140653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Stimulants and Narcotics by Liquid Chromatography-Tandem Mass Spectrometry and Gas Chromatography-Mass Spectrometry for Sports Doping Control.
    Ahrens BD; Kucherova Y; Butch AW
    Methods Mol Biol; 2016; 1383():247-63. PubMed ID: 26660193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology - An update.
    Remane D; Wissenbach DK; Peters FT
    Clin Biochem; 2016 Sep; 49(13-14):1051-71. PubMed ID: 27452180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.